Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07021859 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date changed from estimate of Jun 10, 2025 to Jun 27, 2025v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.
Trial Details
NCT Number NCT07021859
Lead Sponsor Danish Headache Center
Conditions
(from sponsor)		 Migraine Aura, Migraine With Aura
Related terms Epilepsy, Migraine Disorders, Migraine with Aura
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov